Welcome to the Ypsomed Blog

Stay informed with expert insights on digital selfcare, connected drug delivery, and the future of self-medication. The Ypsomed blog is your go-to source for trends, innovations, and thought leadership in the evolving healthcare landscape.

Self-injection device manufacturing in a dynamic world

How did pen-inspired injectors evolve into today’s flexible self-injection platforms? Discover the trends in usability, scale-up, and resilient manufacturing that are shaping the future of drug delivery in a fast-changing industry landscape.

Sustainable GLP-1 drug delivery

GLP-1 therapies are entering a high-growth phase, driving demand for scalable, sustainable delivery solutions. As formulations evolve, device usability, and environmental impact becomes a key industry challenge.

CE-certified reusable pens: Immediate certification for market access

Discover how Ypsomed’s CE-certified reusable pens, ServoPen and YpsoPen, streamline market access. Our innovative platform model simplifies compliance, accelerates product availability, and provides comprehensive support to pharmaceutical partners at …

A fresh look at how patients interact with pen injectors

How do patients handle pen injectors, and what forces do they apply during use? How can these findings shape the design of future devices to improve comfort and usability, especially for those with dexterity challenges?

Ypsomed’s platform product transformation and approach to strategic partner networking

Over the last 40 years, we have been at the forefront of the development and manufacturing of self-injection systems. How has Ypsomed transformed the market for platform-based self-injection devices?

How diabesity is shaping the world of self-injection devices

Innovative peptide hormone molecules for treating diabetes and obesity are fundamentally changing the market for self-injection systems and the demand for pens and autoinjectors continues to increase.

Milestones in manufacturing: Mastering UnoPen and YpsoPen success

UnoPen and YpsoPen are two of Ypsomed’s platforms developed and customized on behalf of various pharma customers for patients dependent on insulin but also GLP-1, hGH, FSH and PTH. Demand for these devices has now exceeded the total of 100 million …

Notice